Accelerating Vaccine Development and Large-Scale Manufacturing with Advanced Purification Tools

Join this GEN webinar, sponsored by Thermo Fisher Scientific, and learn more on novel purification solutions that can help accelerate early vaccine candidate screening and improve the downstream process of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs). In addition, a new scavenging method for the removal of Baculovirus process impurities will be presented.
Thermo Fisher illustration

Scalable AAV Manufacturing: Addressing Challenges Across the Workflow

In this GEN webinar, sponsored by Thermo Fisher Scientific, our presenters will highlight upstream and downstream solutions across the AAV production workflows. Specifically, we will learn about scalable, high-titer AAV production in two cell host systems.
Coronavirus

High-Throughput Proteomics During a Pandemic

In this GEN webinar, sponsored by Bruker, our esteemed presenter Dr. Roman Fischer from the University of Oxford, will showcase the application and limitations of high-throughput timsTOF Pro mass spectrometry on large scale clinical sample sets in order to stratify patients and contribute to a multi-omics blood atlas of COVID-19 patients, and the combination of laser capture microdissection with proteomics methods for the 3D characterization of large biological macrostructures such as organs or tumors.
Coronavirus COVID-19 and blood cells in bloodstream

Accelerating Vaccine Development Using a Next-Gen Microfluidic CE Platform

In this GEN webinar, sponsored by PerkinElmer, we will find out about an exciting protein characterization system that addresses many of the challenges researchers face during vaccine development projects. We will also learn about key applications of microfluidic chip-capillary electrophoresis in vaccine process development.

Recently Featured

Scroll Up